Abstract:Numerous studies suggest that several long non‐coding RNAs (lncRNAs) play critical roles in bladder cancer development and progression. Long non‐coding RNA urothelial cancer‐associated 1 (lncRNA‐UCA1) is highly expressed in bladder cancer tissues and cells, and it has been shown to play an important role in regulating aggressive phenotypes of bladder cancer cells. However, little is known about the molecular mechanism of lncRNA‐UCA1‐mediated bladder cancer cell migration and invasion. Here, we show that overex… Show more
“…UCA1 is a sensitive and specific oncogenic lncRNA in bladder cancer (16). Consistent with previous observations that high UCA1 expression was involved in cell invasion in many cancers as well as bladder cancer (24,36,37), our results clearly showed that cells with stronger invasion capabil ity had higher UCA1 expression levels in bladder cancer cell lines in vitro. EMT is a well-characterized process that facilitates invasion and metastatic dissemination of human cancers (3,4).…”
Section: Discussionsupporting
confidence: 91%
“…To investigate the potential mechanism by which UCA1 regulates EMT in bladder cancer cells, we examined the effect of UCA1 on the expression of HMGB1, which is reported to be associated with the invasion ability of many types of human cancers including bladder cancer (24). qRT-PCR showed that HMGB1 mRNA expression was significantly (P<0.05) reduced by knockdown of UCA1 in T24 cells and increased by overexpression of UCA1 in RT4 cells (Fig.…”
Section: Uca1 Promoted the Invasion And Emt Of Bladder Cancer Cells Bmentioning
confidence: 99%
“…Previous studies revealed that UCA1 expression is associated with enhanced invasion ability of bladder cancer cells (24,36,37). We first investigated the relationship between the expression of UCA1 and the invasion ability of five bladder cancer cell lines.…”
Section: Uca1 Modulated the Invasion And Emt Of Bladder Cancer Cellsmentioning
confidence: 99%
“…UCA1 is highly expressed in diverse cancer types, such as breast cancer (17), pancreatic cancer (18), gastric cancer (19), and colorectal cancer (20,21), suggesting that high expression of UCA1 might serve as a molecular marker for predicting metastasis and prognosis in these cancers (22). Several studies also demonstrated that upregulation of UCA1 is associated with EMT in breast cancer (23) and bladder cancer (24), but the underlying mechanism remains largely unknown.…”
Abstract. The long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) is an oncogenic lncRNA in bladder cancer, and its upregulation is associated with enhanced cell invasion. However, the underlying mechanism remains to be elucidated. The present study demonstrated that UCA1 was positively associated with cell invasion ability and promoted epithelial-mesenchymal transition (EMT) of bladder cancer cells by inducing high mobility group box 1 (HMGB1). Furthermore, bioinformatics and luciferase reporter assays demonstrated binding sites of the tumor suppressive miR-143 within UCA1 and the 3'untranslated region of HMGB1. UCA1 negatively regulated miR-143 expression in a dose-dependent manner in bladder cancer cells. In addition, UCA1 and HMGB1 were upregulated and miR-143 was downregulated in bladder cancer specimens. Overall, the data suggested that UCA1 may promote the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway, which exhibits an important regulatory role in the pathology of bladder cancer.
“…UCA1 is a sensitive and specific oncogenic lncRNA in bladder cancer (16). Consistent with previous observations that high UCA1 expression was involved in cell invasion in many cancers as well as bladder cancer (24,36,37), our results clearly showed that cells with stronger invasion capabil ity had higher UCA1 expression levels in bladder cancer cell lines in vitro. EMT is a well-characterized process that facilitates invasion and metastatic dissemination of human cancers (3,4).…”
Section: Discussionsupporting
confidence: 91%
“…To investigate the potential mechanism by which UCA1 regulates EMT in bladder cancer cells, we examined the effect of UCA1 on the expression of HMGB1, which is reported to be associated with the invasion ability of many types of human cancers including bladder cancer (24). qRT-PCR showed that HMGB1 mRNA expression was significantly (P<0.05) reduced by knockdown of UCA1 in T24 cells and increased by overexpression of UCA1 in RT4 cells (Fig.…”
Section: Uca1 Promoted the Invasion And Emt Of Bladder Cancer Cells Bmentioning
confidence: 99%
“…Previous studies revealed that UCA1 expression is associated with enhanced invasion ability of bladder cancer cells (24,36,37). We first investigated the relationship between the expression of UCA1 and the invasion ability of five bladder cancer cell lines.…”
Section: Uca1 Modulated the Invasion And Emt Of Bladder Cancer Cellsmentioning
confidence: 99%
“…UCA1 is highly expressed in diverse cancer types, such as breast cancer (17), pancreatic cancer (18), gastric cancer (19), and colorectal cancer (20,21), suggesting that high expression of UCA1 might serve as a molecular marker for predicting metastasis and prognosis in these cancers (22). Several studies also demonstrated that upregulation of UCA1 is associated with EMT in breast cancer (23) and bladder cancer (24), but the underlying mechanism remains largely unknown.…”
Abstract. The long non-coding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) is an oncogenic lncRNA in bladder cancer, and its upregulation is associated with enhanced cell invasion. However, the underlying mechanism remains to be elucidated. The present study demonstrated that UCA1 was positively associated with cell invasion ability and promoted epithelial-mesenchymal transition (EMT) of bladder cancer cells by inducing high mobility group box 1 (HMGB1). Furthermore, bioinformatics and luciferase reporter assays demonstrated binding sites of the tumor suppressive miR-143 within UCA1 and the 3'untranslated region of HMGB1. UCA1 negatively regulated miR-143 expression in a dose-dependent manner in bladder cancer cells. In addition, UCA1 and HMGB1 were upregulated and miR-143 was downregulated in bladder cancer specimens. Overall, the data suggested that UCA1 may promote the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway, which exhibits an important regulatory role in the pathology of bladder cancer.
“…In vitro study revealed that MVIH could promote cell proliferation and cell cycle, while inhibiting apoptosis of breast cancer cells. Xue et al (2016) reported that lncRNA urothelial cancer-associated 1 (UCA1) promoted the migration and invasion of bladder cancer cells via regulating the miR-145/ zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2)/fascin homologue 1 (FSCN1) pathway. Therefore, understanding the exact roles of specific lncRNAs may contribute to the development of the diagnostics and therapeutics of human cancers.…”
Lung cancer is the most common human cancer, and the majority of lung cancer cases are categorized as non-small cell lung cancer (NSCLC). Long non-coding RNAs (lncRNAs) play key roles in the development and progression of human cancers. LncRNA breast cancer anti-estrogen resistance 4 (BCAR4) has been identified as an oncogenic lncRNA involved in the progression of breast cancer and osteosarcoma. However, the clinical significance of the lncRNA BCAR4 in NSCLC remains largely unclear. In the present study, real-time quantitative reverse transcriptase-polymerase chain reaction was used to examine the relative level of lncRNA BCAR4 in 68 cases of NSCLC tissues and their adjacent non-tumor tissues. Our data showed that the expression level of lncRNA BCAR4 was significantly higher in NSCLC tissues compared to their matched non-tumor tissues. Moreover, BCAR4 expression was significantly upregulated in NSCLC cell lines, when compared to the normal human bronchial epithelial cell line BEAS-2B. In addition, the BCAR4 expression was associated with the lymph node metastasis, distant metastasis and clinical stage, but not with the age, sex, tumor size, histological grade, and histological type. The increased expression of BCAR4 was significantly associated with poorer 5-year overall survival rate of NSCLC patients. Multivariate survival analysis indicated that BCAR4 was an independent prognostic factor for NSCLC patients. Taken together, our study suggests that the upregulation of lncRNA BCAR4 expression plays a promoting role in the malignant progression of NSCLC. Thus, BCAR4 is a potential biomarker for NSCLC progress and a therapeutic target for NSCLC.
Long non-coding RNAs (lncRNAs) are a major subset of highly conserved non-coding RNAs (ncRNAs) that consist of at least 200 nucleotides and have limited protein-coding potential. Cumulative data have shown that lncRNAs are deregulated in many types of cancer and may control pathophysiological processes of cancer at various levels, including transcription, post-transcription and translation. Recently, lncRNAs have been demonstrated to interact with microRNAs (miRNAs), another major subset of ncRNAs, which regulate physiological and pathological processes by inhibiting target mRNA translation or promoting mRNA degradation. The lncRNA urothelial carcinomaassociated 1 (UCA1) has recently gained much attention as it is overexpressed in many types of cancer and is involved in carcinogenesis. Here, we review the crosstalk between UCA1 and miRNAs during the pathogenesis of cancer, with a focus on cancer-cell proliferation, invasion, drug resistance, and metabolism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.